Bullous Pemphigoid: Symptoms, Causes & UK Online Doctor Advice

Bullous pemphigoid is a rare, long-term autoimmune skin condition characterised by large, firm, fluid-filled blisters. While the name may sound complex, it describes a process where the body's immune system mistakenly attacks the thin layer of tissue just below the outer layer of skin. This results in inflammation and the formation of blisters (bullae) that do not easily rupture.

In the UK, this condition is most commonly diagnosed in people over the age of 60, though it can occasionally affect younger adults. Unlike some other blistering conditions, bullous pemphigoid is not contagious and cannot be passed from person to person. According to NICE (National Institute for Health and Care Excellence) guidelines, management focuses on controlling the symptoms and preventing complications such as skin infections.

The symptoms of bullous pemphigoid often appear in stages. For many patients, the first sign is not a blister, but an intense, persistent itch that can be mistaken for eczema or hives. This 'pre-eruptive' stage can last for weeks or even months.

Common signs include:

• Large Blisters: These are typically firm, clear, and measuring 1cm to 5cm in diameter. They usually appear on the arms, legs, lower abdomen, or groin.
• Intense Itching: The pruritus (itching) is often severe and can disrupt sleep and daily activities.
• Red or Darkened Patches: The skin may develop a rash that looks like welts or hives before the blisters actually form.
• Mouth Sores: In about 10-20% of cases, blisters or erosions may appear on the gums or inside the cheeks.
• Fluid Changes: The fluid inside the blisters is usually clear but may occasionally be tinged with blood.

The exact trigger for bullous pemphigoid is not always clear, but it is fundamentally an autoimmune disorder. The immune system produces antibodies that attack the 'basement membrane'—the glue that holds the epidermis (top layer) to the dermis (bottom layer). When these layers separate, fluid fills the gap, creating a blister.

While most cases occur spontaneously, certain factors may increase the risk or trigger a flare-up:

• Age: The risk increases significantly as you get older, particularly after age 70.
• Medications: Certain drugs, such as some diuretics (water tablets), penicillin, and non-steroidal anti-inflammatory drugs (NSAIDs), have been linked to triggers.
• Light and Radiation: Ultraviolet light therapy for other skin conditions or radiotherapy for cancer can occasionally provoke the condition.
• Underlying Health Issues: There is a documented association between bullous pemphigoid and certain neurological conditions, such as Parkinson's disease or stroke.

If you suspect you have bullous pemphigoid, it is vital to seek medical advice promptly. A GP will typically examine the skin and ask about your medical history. Because the symptoms can mimic other rashes, a definitive diagnosis usually requires further testing by a dermatologist.

Standard NHS diagnostic pathways include a skin biopsy, where a small sample of skin and a blister is removed under local anaesthetic. This sample is then examined under a microscope. A specific test called direct immunofluorescence (DIF) is used to look for the antibodies attacking the skin. Blood tests may also be conducted to check for specific pemphigoid antibodies in the circulation.

The primary goal of treatment is to stop new blisters from forming and help existing ones heal. Following NICE clinical knowledge summaries, the mainstay of treatment is corticosteroids.

Common treatments include:

• Topical Steroids: High-potency steroid creams (such as clobetasol propionate) are often preferred for localised or even moderate cases, as they have fewer systemic side effects than tablets.
• Oral Steroids: For widespread blistering, a course of prednisolone tablets may be prescribed to quickly reduce inflammation.
• Immunosuppressants: If steroids alone are not enough, or to help reduce the steroid dose, medications like azathioprine or methotrexate may be used.
• Antibiotics: Sometimes, antibiotics like tetracycline or nicotinamide are used for their anti-inflammatory properties rather than to treat infection.

It is important to follow the prescribed regimen strictly, as stopping steroids suddenly can cause a severe rebound flare-up.

Managing a chronic skin condition requires regular monitoring. You may wish to speak to a GP online if you notice a new itchy rash that isn't responding to over-the-counter creams, or if you have been previously diagnosed and are experiencing a flare-up.

An online doctor can review your symptoms via a video consultation, provide advice on skin care, and issue prescriptions for topical treatments if appropriate. If your symptoms are severe or atypical, they can provide a referral to a specialist dermatologist. Accessing an online GP service is a convenient way to get a professional opinion without the wait times often associated with local surgeries, ensuring your treatment starts as soon as possible.

Self-care is a crucial part of recovery. Patients should avoid popping blisters, as the intact skin acts as a natural sterile dressing. If a blister does burst, keep the area clean and apply a non-adherent dressing to prevent infection. Soft, loose-fitting cotton clothing can help reduce friction on the skin.

Most patients will find that the condition enters a period of remission after one to five years of treatment. During this time, the medication dose is gradually 'tapered' down under medical supervision. Regular follow-ups are essential to monitor for side effects of long-term steroid use, such as thinning skin or increased blood pressure.